![]() ![]() Bacterial strain typing and genomics characterization of multi-drug resistance with QIAGEN CLC Genomics Workbench (March 9, 2020).Scaling your bioinformatics with QIAGEN CLC Genomics Server and Cloud Engine (March 25, 2020).Bioinformatics analysis of Nanopore sequencing data for SARS-CoV-2 (April 2, 2020).Using QIAGEN Digital Insights to research coronavirus fusion and immune control (May 6, 2020).QIAGEN CLC User Group Meeting (May 26 and 27, 2020) Watch the on-demand presentations from this online event, including talks on QIAGEN CLC core and advanced capabilities, use cases from KOLs and a discussion on SARS-CoV-2 analysis using CLC Genomics Workbench.QIAGEN CLC Genomics resources for microbial and viral genomics Webinars * Offer not available in combination with other offers. To help them accelerate impactful insights, with every purchase of this kit they receive 25% off any 1-year subscription to QIAGEN CLC Genomics bioinformatics software. In addition, we have a special offer* for labs that purchase the QIAseq SARS-CoV-2 Primer Panel Kit (96). To support these efforts, QIAGEN Digital Insights is offering laboratories involved in COVID-19 research and the global pandemic response free 14-day temporary licenses to QIAGEN CLC Genomics Workbench Premium and QIAGEN IPA. QIAGEN Ingenuity Pathway Analysis (IPA) is used by thousands of researchers worldwide and cited extensively in studies of the host response to viruses. QIAGEN CLC Genomics has also been critical for many labs on the front lines of the COVID-19 pandemic involved in sequencing the SARS-CoV-2 virus. QIAGEN CLC Genomics Workbench software is used by hundreds of microbiology and virology labs around the world for basic research and infectious disease epidemiology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |